Recursion Pharmaceuticals Inc Clas (RXRX)

Operating Income Growth

23.41%

Quarterly · Period ending:

RXRX logo

RXRX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported23.41%
RXRX Quarterly Operating Income YoY % (-66.19% → 23.41%)
High-resolution chart · PNG

RXRX operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Operating Income Growth — Quarterly
Period endingOperating Income Growth
23.4124%
32.8493%
41.0485%
-75.0839%
-75.2753%
-98.6382%
-85.7556%
1.2014%
-23.0411%
-37.8945%
-62.2282%
-59.0942%
-23.4533%
-24.8013%
6.1238%
-34.8498%
-61.7215%
-83.6406%
-153.9385%
-106.4697%
-124.6748%
-66.1887%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.